Barrett Esophagus
-
Subject Areas on Research
- A UK-based cost-utility analysis of radiofrequency ablation or oesophagectomy for the management of high-grade dysplasia in Barrett's oesophagus.
- Ablative therapies for Barrett's esophagus.
- Advanced imaging and technology in gastrointestinal neoplasia: summary of the AGA-NCI Symposium October 4-5, 2004.
- Angle-resolved low coherence interferometry for detection of dysplasia in Barrett's esophagus.
- Angle-resolved low-coherence interferometry: an optical biopsy technique for clinical detection of dysplasia in Barrett's esophagus.
- Barrett's esophagus and esophageal cancer: Links to microbes and the microbiome.
- Barrett's esophagus and β-carotene therapy: symptomatic improvement in GERD and enhanced HSP70 expression in esophageal mucosa.
- Barrett's esophagus in 2008: an update.
- Buried metaplasia after endoscopic ablation of Barrett's esophagus: a systematic review.
- Cellular origins and molecular mechanisms of Barrett's esophagus and esophageal adenocarcinoma.
- Circumferential ablation of Barrett's esophagus that contains high-grade dysplasia: a U.S. Multicenter Registry.
- Cost-effectiveness of photodynamic therapy for high-grade dysplasia in Barrett's esophagus.
- Design and validation of an angle-resolved low-coherence interferometry fiber probe for in vivo clinical measurements of depth-resolved nuclear morphology.
- Detection of dysplasia in Barrett's esophagus with in vivo depth-resolved nuclear morphology measurements.
- Endoscopic fluorescence detection of high-grade dysplasia in Barrett's esophagus.
- Esophageal adenocarcinoma in a patient with surgically treated achalasia.
- Esophageal cancer.
- Esophageal submucosal glands as a potential source of subsquamous intestinal metaplasia in Barrett's esophagus.
- Expert pathology review and endoscopic mucosal resection alters the diagnosis of patients referred to undergo therapy for Barrett's esophagus.
- Expression of SOX9 and CDX2 in nongoblet columnar-lined esophagus predicts the detection of Barrett's esophagus during follow-up.
- Feasibility, safety, acceptability, and yield of office-based, screening transnasal esophagoscopy (with video).
- Gastroesophageal reflux and esophagitis in infants and children.
- Hepatocyte paraffin 1 antigen as a biomarker for early diagnosis of Barrett esophagus.
- High yield reproducible rat model recapitulating human Barrett's carcinogenesis.
- Hypermethylated APC DNA in plasma and prognosis of patients with esophageal adenocarcinoma.
- In situ detection of nuclear atypia in Barrett's esophagus by using angle-resolved low-coherence interferometry.
- LGR5 in Barrett's Esophagus and its Utility in Predicting Patients at Increased Risk of Advanced Neoplasia.
- Laser-induced fluorescence for esophageal cancer and dysplasia diagnosis.
- Measuring the quality of Barrett's esophagus management with measures that are high quality.
- MicroRNA expression differentiates squamous epithelium from Barrett's esophagus and esophageal cancer.
- Molecular biology of esophageal cancer.
- Nuclear morphology measurements with angle-resolved low coherence interferometry for application to cell biology and early cancer detection.
- Overutilization of endoscopic surveillance in nondysplastic Barrett's esophagus: a multicenter study.
- Pathogenesis and Cells of Origin of Barrett's Esophagus.
- Photodynamic therapy of Barrett's esophagus: ablation of Barrett's mucosa and reduction in p53 protein expression after treatment.
- Plasmonic nanobiosensors for detection of microRNA cancer biomarkers in clinical samples.
- Prevention of Barrett esophagus and esophageal adenocarcinoma by smoothened inhibitor in a rat model of gastroesophageal reflux disease.
- Prior tonsillectomy is associated with an increased risk of esophageal adenocarcinoma.
- Quality of life in patients with Barrett's esophagus undergoing surveillance.
- Reducing hospital morbidity and mortality following esophagectomy.
- Serial Endoscopic Evaluation of Esophageal Disease in a Cancer Model: A Paradigm Shift for Esophageal Adenocarcinoma (EAC) Drug Discovery and Development.
- Sex-Specific Genetic Associations for Barrett's Esophagus and Esophageal Adenocarcinoma.
- Survival of patients with carcinoma of the esophagus treated with combined-modality therapy.
- The association of gastric leptin with oesophageal inflammation and metaplasia.
- The effect of reactive atypia/inflammation on the laser-induced fluorescence diagnosis of non-dysplastic Barrett's esophagus.
- Tissue culture of epithelium derived from Barrett's oesophagus.
-
Keywords of People
- Garman, Katherine Schuver, Associate Professor of Medicine, Medicine, Gastroenterology